While COVID-19 cases are surging in South Africa off the back of the dominant Delta variant, the flu virus has virtually vanished. Only 50 influenza cases have been detected so far this year through the country’s influenza monitoring system. Adele Baleta unpacks what is going on.
An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.
With the COVID-19 mass vaccination rollout set to start on 17 May, many more people, for now, those older than 60 years, will receive their jabs. Elri Voigt looked into what, if anything, will change for those who have been vaccinated, and what other countries have done in this regard.
A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.
Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.
Every year around 40 000 people are hospitalised with influenza in South Africa and around 11 000 die of the disease. Spotlight interviewed leading Professor in Vaccinology Shabir Madhi about the flu and its implications for the fight against COVID-19.